Winston Medical Supply Co., Ltd. (TPEX:6817)
Taiwan · Delayed Price · Currency is TWD 50.80
-1.20 (-2.31%)
Jul 30, 2026, 1:09 PM CST
Winston Medical Supply Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 958 | 1,519 | 1,681 | 1,809 | 1,138 | 1,368 | |
Market Cap Growth | -52.94% | -9.64% | -7.03% | 58.90% | -16.80% | - |
Enterprise Value | 707 | 1,215 | 1,386 | 1,585 | 1,011 | 1,265 |
Last Close Price | 52.00 | 75.96 | 78.81 | 80.18 | 47.70 | 54.59 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.19 | 12.95 | 12.78 | 11.39 | 10.23 | 14.85 |
PS Ratio | 1.37 | 2.17 | 2.42 | 2.55 | 1.88 | 2.55 |
PB Ratio | 2.24 | 3.55 | 3.83 | 4.23 | 3.15 | 4.21 |
P/TBV Ratio | 2.25 | 3.57 | 3.85 | 4.25 | 3.16 | 4.24 |
P/FCF Ratio | 6.92 | 10.97 | 12.91 | 9.21 | 9.61 | 9.67 |
P/OCF Ratio | 6.18 | 9.80 | 11.36 | 8.39 | 9.11 | 9.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.01 | 1.74 | 1.99 | 2.24 | 1.67 | 2.36 |
EV/EBITDA Ratio | 4.21 | 7.38 | 7.49 | 7.16 | 5.90 | 8.48 |
EV/EBIT Ratio | 4.98 | 8.57 | 8.70 | 8.08 | 7.44 | 10.98 |
EV/FCF Ratio | 5.10 | 8.77 | 10.64 | 8.07 | 8.54 | 8.95 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.11 | 0.11 | 0.13 | 0.15 | 0.17 | 0.21 |
Debt / EBITDA Ratio | 0.29 | 0.29 | 0.30 | 0.29 | 0.36 | 0.45 |
Debt / FCF Ratio | 0.35 | 0.35 | 0.43 | 0.33 | 0.52 | 0.48 |
Net Debt / Equity Ratio | -0.59 | -0.59 | -0.55 | -0.55 | -0.39 | -0.29 |
Net Debt / EBITDA Ratio | -1.52 | -1.52 | -1.32 | -1.06 | -0.82 | -0.63 |
Net Debt / FCF Ratio | -1.81 | -1.81 | -1.87 | -1.20 | -1.19 | -0.67 |
Asset Turnover | 0.88 | 0.88 | 0.86 | 0.94 | 0.91 | 0.83 |
Inventory Turnover | 2.64 | 2.64 | 2.86 | 3.41 | 3.38 | 2.79 |
Quick Ratio | 1.46 | 1.46 | 1.50 | 1.58 | 1.48 | 1.25 |
Current Ratio | 1.99 | 1.99 | 2.01 | 2.01 | 1.89 | 1.75 |
Return on Equity (ROE) | 27.06% | 27.06% | 30.35% | 40.21% | 32.39% | 30.27% |
Return on Assets (ROA) | 11.12% | 11.12% | 12.33% | 16.31% | 12.69% | 11.13% |
Return on Invested Capital (ROIC) | 64.38% | 61.09% | 65.70% | 75.68% | 47.33% | 35.93% |
Return on Capital Employed (ROCE) | 29.60% | 29.60% | 31.70% | 39.00% | 31.00% | 28.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.25% | 7.72% | 7.83% | 8.78% | 9.78% | 6.73% |
FCF Yield | 14.46% | 9.11% | 7.75% | 10.86% | 10.41% | 10.34% |
Dividend Yield | 9.28% | 6.58% | 8.88% | 8.23% | 10.48% | 7.33% |
Payout Ratio | 109.91% | 109.91% | 92.37% | 58.00% | 66.21% | 59.97% |
Buyback Yield / Dilution | 0.05% | 0.05% | 0.04% | - | -0.27% | -3.93% |
Total Shareholder Return | 9.33% | 6.64% | 8.92% | 8.23% | 10.22% | 3.40% |